Filter
979
Text search:
injectable
Featured
Recommendations
133
New Publications
329
Language
Document type
No document type
604
Guidelines
174
Studies & Reports
90
Manuals
40
Fact sheets
27
Strategic & Response Plan
16
Training Material
15
Situation Updates
8
Brochures
2
App
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
49
Senegal
37
Kenya
34
Western and Central Europe
31
Congo, Democratic Republic of
25
Nepal
25
Malawi
24
Nigeria
23
South Africa
21
Global
21
Ethiopia
20
Eastern Europe
20
Bangladesh
18
Tanzania
17
Zambia
16
Rwanda
16
Burkina Faso
15
Benin
14
Uganda
13
Sierra Leone
12
Namibia
12
Liberia
11
Myanmar / Burma
11
Cameroon
10
Haiti
10
Guinea
9
Latin America and the Carribbean
9
Africa
9
Ghana
8
Philippines
8
Zimbabwe
6
West and Central Africa
6
Mali
5
Mozambique
5
Botswana
5
Madagascar
5
Middle East and North Africa
5
Cambodia
4
Ukraine
4
East and Southern Africa
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Côte d’Ivoire / Ivory Coast
3
Pakistan
3
Syria
3
Brazil
3
Albania
3
Tajikistan
3
Russia
3
Georgia
3
Morocco
2
Lebanon
2
Eswatini/ Swaziland
2
Lesotho
2
Asia
2
Iran
2
Guinea-Bissau
1
USA
1
Saudi Arabia
1
Niger
1
Togo
1
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Turkey
1
Chad
1
Gambia
1
Indonesia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Serbia
1
Colombia
1
Greece
1
Libya
1
Sri Lanka
1
Armenia
1
Timor Leste/ East Timor
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
France
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
445
Clinical Guidelines
162
Women & Child Health
96
Public Health
49
Capacity Building
19
Key Resources
18
Pharmacy & Technologies
13
Toolboxes
TB
149
HIV
73
Pharmacy
52
COVID-19
39
Caregiver
29
Mental Health
21
Ebola
15
Rapid Response
15
AMR
15
NCDs
14
NTDs
12
Conflict
11
Polio
8
Refugee
7
Cholera
6
Natural Hazards
2
Planetary Health
2
Zika
1
Specific Hazards
1
Social Ethics
1
Health Financing Toolbox
1
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w
...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The revision of the SRHR Policy is based on the results of the analysis of the implementation process of the past policy, which has provided evidence to
ensure that the revised policy is relevant and effective. The revision has also been done with the participation of all national stakeholders who
...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll
...
Les médicaments ont été classés à la fois par classe pharmaco-thérapeutique et par ordre alphabétique. La présence d’une marque astérisque renvoie à davantage de précision pour le (les) médicament(s) concerné(s).
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im
...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a
...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the
...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome
...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr
...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep
...
Disease epidemiology has a deeper relationship with the dynamic nature of culture. Health behaviors in general are largely shaped by the cultural norms and customs in a society. A mere identification of a behavior could be only a layer on the outer sphere of a particular disease epidemiology and the
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio
...
